A pharmaceutical export shipment is not one transaction. It is a chain of about a dozen smaller steps, each dependent on the one before it, spread across two regulatory systems and three or four companies.
Most first-time importers assume the hard part is finding a supplier and agreeing a price. In practice the price takes a week and the regulatory work takes months.
What is the pharmaceutical export process? Pharmaceutical export is the regulated sale and international shipment of medicines, APIs, or finished dosage forms. It moves through enquiry, quotation, sample and document exchange, product registration, purchase order, manufacturing, quality release, export packaging, documentation, customs clearance, freight, and delivery at the destination port.
Table of Contents
- Who Does What
- Step 1: Buyer Enquiry
- Step 2: Quotation and Incoterms
- Step 3: Samples and COA Exchange
- Step 4: Product Registration
- Step 5: Purchase Order and Payment
- Step 6: Manufacturing
- Step 7: Quality Release
- Step 8: Packaging and Labelling
- Step 9: Pre-Shipment Documents
- Step 10: Customs and Freight
- Step 11: Cold Chain
- Step 12: Port of Entry
- Step 13: Post-Shipment Support
- Expert Tips
- Common Mistakes
- Frequently Asked Questions
<a id=”who-does-what”></a>
Who Does What in a Pharmaceutical Export Transaction
The exporter — manufacturer or export house. Owns the product, its quality documents, export packaging, and the commercial document set.
The importer — the buyer. Holds the import licence and usually the marketing authorisation, and handles local registration and clearance.
The CHA and freight forwarder — the broker files customs declarations; the forwarder books the vessel or aircraft and issues the transport document.
The regulatory authorities — one at each end, controlling what leaves and enters. Their timelines are not negotiable.
The bank — under a letter of credit, banks check documents before money moves.
<a id=”step-1″></a>
Step 1: Buyer Enquiry and Product Identification
Every order starts with an enquiry. A good one is specific: molecule, strength, dosage form, pack size, quantity, and destination country.
The destination matters more than buyers expect. It sets the regulatory pathway, the pharmacopoeial standard, and sometimes whether the product can be supplied at all.
The exporter checks whether the site’s approval status matches the market, whether the molecule may be imported, and whether the requested grade — USP, BP, EP, IP — is the one the buyer needs.
A buyer who orders BP grade but registers a USP specification ends up with stock that fails its own registered spec.
<a id=”step-2″></a>
Step 2: Quotation and Incoterms
The exporter issues a quotation or proforma invoice carrying unit price, minimum order quantity, pack configuration, lead time, validity, and the Incoterm.
The Incoterm decides where the seller’s responsibility ends, and who pays freight, insurance and clearance. Two quotes that look different may be identical once normalised to the same term.
| Incoterm | Seller delivers at | Freight paid by seller | Insurance | Typical use |
|---|---|---|---|---|
| EXW | Factory gate | No | Buyer | Buyer has a strong origin-country forwarder |
| FOB | On board vessel, origin port | To port only | Buyer | Sea, buyer controls main leg |
| CIF | Origin port, paid to destination port | Yes | Seller, minimum cover | Sea, buyer wants a port-landed price |
| CIP | Named destination place | Yes | Seller, higher cover | Air and multimodal, common in pharma |
CIP is the usual default for high-value or temperature-sensitive cargo, since it suits air freight and requires broader cover. Confirm the Incoterms edition, as insurance duties changed in 2020.
<a id=”step-3″></a>
Step 3: Samples, COA and Technical Documents
Before any commercial order the buyer requests samples and technical documents. This is where their quality team decides whether the supplier is credible.
A first exchange covers a Certificate of Analysis for a recent batch, the specification, the method of analysis, a safety data sheet, and the site’s GMP certificate. For APIs, buyers also ask about Drug Master File availability.
Read the COA against the specification, not on its own. Results sitting at the edge of the limit on assay or related substances say something about process control.
Samples ship as non-commercial goods at a nominal value and often need a sample import permit.
<a id=”step-4″></a>
Step 4: Product Registration in the Destination Country
This is the longest step in pharmaceutical export and the most underestimated. In nearly every regulated market a finished product cannot be imported for sale until it holds a marketing authorisation there.
The importer normally holds it, because most authorities require a locally established licence holder. The exporter supplies the technical dossier, Certificate of Pharmaceutical Product, manufacturing licence, GMP certificate, stability data and validation summaries.
Timelines vary widely, and stringent authorities may require a site inspection first. Plan launch dates around the regulatory calendar, not the production calendar.
APIs follow a different route. The manufacturer supports the customer’s filing through a Drug Master File, keeping confidential process detail out of the buyer’s hands.
<a id=”step-5″></a>
Step 5: Purchase Order and Payment Terms
The buyer issues a purchase order against the accepted proforma invoice. It should mirror the quotation exactly — product, strength, pack, quantity, price, Incoterm, delivery port and shelf life.
Shelf life deserves its own clause. Many importing countries refuse consignments with less than 60 to 75 percent of shelf life remaining at entry.
| Term | How it works | Exporter risk | Importer risk | Typical use |
|---|---|---|---|---|
| Advance TT | Wire transfer before dispatch | Low | Higher | New relationships, small orders |
| Letter of Credit | Bank pays against compliant documents | Low if documents are clean | Moderate, funds blocked | Larger or first cross-border orders |
| DP | Documents released on payment | Moderate | Lower | Established relationships |
| DA | Documents released against acceptance | Higher | Low | Long-standing buyers with credit history |
Letters of credit fail on paperwork far more often than on money. A misspelled consignee or a mismatched description creates a discrepancy the bank can refuse.
<a id=”step-6″></a>
Step 6: Manufacturing and Batch Allocation
Once the order is firm, production is scheduled — a manufacturer allocates a batch, an export house books allocation from a partner site.
Export batches are rarely interchangeable with domestic stock. Destination artwork, language and pack sizes mean a dedicated run, recorded in its own Batch Manufacturing Record.
Lead time depends on raw material availability more than line capacity. Ask for starting material status, not just the production slot.
<a id=”step-7″></a>
Step 7: Quality Control Release and Retention Samples
After manufacture the batch sits in quarantine until testing is complete.
QC runs the registered specification: identity, assay, related substances, a performance test such as dissolution, microbial limits, and pack integrity.
Quality assurance then reviews the batch record, the results, and any deviations. Release is a QA decision — the lab produces data, QA decides whether the batch is fit for sale.
Retention samples stay at the site for the shelf life plus a further period set by local rules. If a question arises later, they are what let an investigation conclude.
<a id=”step-8″></a>
Step 8: Pharmaceutical Export Packaging and Labelling
Export packaging must protect the product across a long journey and satisfy destination labelling law. Failing either causes rejection at the port.
Primary packaging is fixed by the registration and cannot change without a variation. Secondary and tertiary packaging is where export-specific work happens.
Artwork usually has to appear in the destination’s official language and carry the generic name, strength, batch number, manufacturing and expiry dates, storage conditions, authorisation number, and local licence holder.
Serialisation applies in many markets — a unique identifier on the saleable pack, aggregation to the shipper carton, and data uploaded to a national repository. It must be built into the packing run.
<a id=”step-9″></a>
Step 9: The Pre-Shipment Document Set
With the batch released and packed, the document set is assembled. Customs, the bank, and the destination authority each read it independently, and every copy must agree.
A consignment travels at minimum with a commercial invoice, packing list, certificate of origin, the COA for each batch, and the transport document — a bill of lading for sea or an air waybill for air. Import permits and a CoPP are added by market.
The most common failure is inconsistency. Description, batch number, quantity, and consignee details must match across every document, because customs officers and banks both work by comparison.
<a id=”step-10″></a>
Step 10: Customs Clearance and Freight Booking
The exporter’s broker files the export declaration under the correct HS code. Pharmaceutical consignments often need a no-objection certificate or drug controller clearance too.
In parallel the forwarder books space. Air or sea shapes cost, transit time, and packaging design.
| Factor | Air freight | Sea freight |
|---|---|---|
| Transit time | Days | Weeks |
| Cost per kg | Considerably higher | Much lower |
| Best for | High value, cold chain, short shelf life, urgent orders | Bulk APIs, large volumes of stable solid dosage forms |
| Temperature control | Passive or active shippers, short exposure | Reefer containers, long exposure needs validation |
| Shelf-life impact | Minimal | Weeks consumed in transit |
| Transport document | Air waybill, non-negotiable | Bill of lading, can be negotiable |
Sea freight is cheaper but eats shelf life. A long ocean transit plus port dwell time can quietly break a remaining-life requirement.
<a id=”step-11″></a>
Step 11: Cold Chain and Temperature Control
Some shipments must stay inside a defined temperature range from release to delivery. Vaccines and biologics are the obvious cases, but a “store below 30°C” instruction on ordinary tablets can also be breached on a summer sea route.
These shipments use qualified packaging validated for a stated duration and ambient profile, with data loggers inside the shipper. Logger data is reviewed before the consignment is accepted.
<a id=”step-12″></a>
Step 12: Port of Entry Inspection and Release
At destination, the importer’s broker files the import declaration. In most countries the drug regulatory authority reviews pharmaceutical consignments separately from customs.
Checks confirm the product matches its registration, the importer holds a valid import licence, labelling meets local law, and remaining shelf life clears the national threshold. Sampling for independent testing is common.
Duties and port charges are paid and the goods released, sometimes under bond until local test results arrive. Delays here are documentary far more often than physical.
<a id=”step-13″></a>
Step 13: Post-Shipment Support
Delivery does not end the exporter’s obligations. Batch documents may need reissuing, and the buyer’s quality team often raises questions at incoming inspection.
Ongoing duties include supplying updated stability data, notifying changes that affect the registration, supporting pharmacovigilance queries, and handling complaints or recalls.
A written quality agreement setting out who investigates what, in what timeframe, is worth more than goodwill.
<a id=”expert-tips”></a>
Expert Tips
- Fix the Incoterm before comparing prices. An EXW price and a CIF price are not comparable numbers until you normalise them.
- Write minimum remaining shelf life into the purchase order. Measure it at entry, not dispatch.
- Review the draft letter of credit line by line. Match description, Incoterm, ports and documents against what you can produce.
- Ask for raw material status, not the production date. A confirmed slot means nothing if a starting material has a long lead time.
- Get artwork approved in writing before the packing run. Label errors surface at the port, and reworking abroad is expensive.
- Send scanned drafts before couriering originals. Ten minutes of checking prevents a bill of lading amendment that costs a week.
- Keep one master data sheet per product and market. Registered name, spec, pack, HS code and licence number in one place.
<a id=”common-mistakes”></a>
Common Pharmaceutical Export Mistakes
- Treating registration as a formality that runs alongside shipping. Goods arrive where the product has no legal status.
- Accepting a domestic-market pack for an export order. Labelling fails destination requirements and the consignment is detained at entry.
- Ignoring the shelf-life rule of the importing country. A sound batch is refused because too much life was consumed in transit.
- Letting details drift between invoice, packing list and COA. Customs queries and LC discrepancies block both release and payment.
- Choosing sea freight purely on cost for a short-shelf-life product. The saving is lost if goods are rejected or discounted.
- Skipping data loggers on temperature-sensitive shipments. No evidence the product stayed in range, so QA cannot accept it.
- Working without a written quality agreement. When a complaint or recall happens, nobody knows who investigates or who pays.
<a id=”faq”></a>
Frequently Asked Questions
What is the pharmaceutical export process in simple terms?
It is the regulated sequence that moves a medicine or API from a manufacturer in one country to a buyer in another. It runs from enquiry and quotation through sample exchange, product registration, purchase order, manufacturing, quality release, export packaging, documentation, customs clearance and freight, ending with inspection and release at the destination port. Regulatory approval usually takes far longer than production or shipping does.
Do I need to register a pharmaceutical product before importing it?
In almost all regulated markets, yes. A finished product needs a marketing authorisation before it can be legally imported for sale, and the importer usually holds it because most authorities require a locally established licence holder. The exporter supports the filing with a technical dossier, GMP certificate, Certificate of Pharmaceutical Product, and stability data. Narrow exceptions exist for named-patient supply and clinical trial material.
Which Incoterm is best for pharmaceutical shipments?
CIP is often the practical choice for air shipments, since it suits multimodal transport and requires broader insurance cover than CIF. FOB and CIF work for sea shipments where the buyer wants control of the main carriage. EXW gives the buyer full responsibility from the factory gate, which only works with a capable forwarder at origin. Confirm the Incoterms edition, since insurance obligations changed in the 2020 rules.
How long does a pharmaceutical export shipment take?
For a product already registered in the destination market, expect weeks from purchase order to delivery by air and longer by sea. Manufacturing lead time and raw material availability drive the schedule more than transport does. For a new product in a new market, registration dominates and can add many months, since review, queries and sometimes a site inspection come first.
What documents are needed for pharmaceutical export?
The core set is a commercial invoice, packing list, certificate of origin, Certificate of Analysis for each batch, and the transport document — a bill of lading for sea or an air waybill for air. Depending on the destination, an import permit, Certificate of Pharmaceutical Product, or fumigation certificate is added. The critical rule is consistency: every detail must match across all documents, because customs and banks check by comparison.
Who arranges customs clearance in a pharmaceutical export order?
Two brokers are normally involved. At origin, the exporter’s customs house agent files the export declaration and obtains any drug controller clearance the exporting country requires. At destination, the importer’s broker files the import declaration and presents documents to customs and the drug regulatory authority. Which side pays depends on the Incoterm: under EXW the buyer handles both ends, while CIF and CIP put carriage on the seller.
What is the difference between air and sea freight for pharmaceuticals?
Air freight takes days and costs considerably more per kilogram, so it suits high-value products, cold chain consignments, short shelf life, and urgent orders. Sea freight takes weeks and costs much less, making it the default for bulk APIs and stable solid dosage forms. Its hidden cost is shelf life: a long transit plus port dwell time can breach the remaining-life threshold enforced at entry.
What happens if a temperature excursion occurs during shipment?
The data logger record is downloaded and reviewed on arrival before the consignment is accepted. An excursion is not automatically fatal. Where stability data supports it, a documented assessment may allow release; where it does not, the goods are rejected. This is why the packaging configuration must be validated, loggers must be included, and acceptance criteria agreed in writing before the goods ship.
Can APIs be exported without a marketing authorisation?
APIs generally do not need a marketing authorisation of their own, because they are not supplied to patients directly. Instead the API manufacturer supports the customer’s finished-product filing through a Drug Master File or an equivalent regional mechanism, letting the authority review confidential manufacturing detail without disclosing it to the buyer. Import licences and GMP evidence are still required in many markets.
What payment terms are normal in pharmaceutical export?
Advance telegraphic transfer, often split between an advance and a balance against documents, is common for new relationships and smaller orders. Letters of credit suit larger consignments and first-time cross-border trade, because the bank guarantees payment against compliant documents. Documents against payment and against acceptance appear once a trading history exists. Credits fail on paperwork far more often than on funds.
<a id=”final-thoughts”></a>
Final Thoughts
Pharmaceutical export rewards preparation over speed. The steps that look like administrative overhead — registration, artwork approval, document checking, shelf-life clauses — are the ones that decide whether a shipment clears smoothly.
Overlap regulatory work with commercial negotiation, and agree shelf life, temperature handling and quality responsibilities in writing.
Discuss Your Sourcing Requirements
If you are planning to import APIs, generics, or finished dosage forms, speak with our pharmaceutical experts before committing to an order. Share your product, destination country, and volumes, and we will outline a realistic timeline and document set.
